Craig D. Steeneck

Director Steeneck bought 2,000 shares of FRPT at $47.83 (now $51.58, -42.6% from 52-week high); cluster of 5 other insiders buying within 14 days.

Craig D. Steeneck, a Director, purchased 2,000 shares at $47.83, increasing his holdings to 37,500 shares (+5.6%). The purchase occurs within a cluster pattern: 5 other insiders also bought FRPT within the past 14 days, suggesting coordinated sentiment at the board or management level. However, the stock's recent momentum is negative: -21.8% over 30 days and -30.8% over 90 days, and Steeneck's own prior buy at this ticker (on 2025-02-24) generated a -20.5% 90-day return, indicating his prior FRPT purchase did not prove well-timed. The company's fundamentals remain solid—$297.6M quarterly revenue with +13.0% annual growth and a 12.64 P/E—but the recent price decline and insider's poor timing history at this specific ticker warrant close attention to whether the cluster buy reflects conviction or other factors.

Director Steeneck Craig D. purchased 2,000 shares of FRPT at $106.28; 5 other insiders also bought within 14 days as stock trades -34.3% from 52-week high.

Craig D. Steeneck, a Director, purchased 2,000 shares at $106.28 on 2025-02-24, increasing his position to 32,479 shares (32.5K shares). This transaction is part of a broader pattern: 5 other insiders also bought within the past 14 days, creating a cluster buy activity during a period of significant price weakness. The stock is currently trading at $106.88, down 34.3% from its 52-week high of $162.59 and down 33.4% over the past 30 days, while the company maintains strong fundamentals with revenue of $253.4M (latest quarter), net income of $11.9M, and annual revenue growth of 27.2%. The synchronized buying by multiple directors during an extended drawdown suggests insiders are accumulating shares at depressed levels relative to the 52-week range, although the stock remains within its annual trading band at current levels.